跳至主要内容
临床试验/JPRN-UMIN000001928
JPRN-UMIN000001928未知2 期

Phase II trial of preoperatively CDDP/S-1 for patients with clinical stage II(exclusion N0 disease) and Stage IIIA non-small cell lung cancer - Induction chemotherapy of CDDP/S-1 for patients with stage II or IIIA non-small cell lung cacer

Thoracic Surgery, Graduate School of Medicine, Chiba University0 个研究点目标入组 35 人开始时间: 2009年5月1日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with severe drug allergy 2)Patients with administration of another 5-fluouracil derivative drugs, flucytosine, phenytoin, warfarin sodium 3)Patients with active concomitant malignancy 4)Patients with active severe infection, diarrhea, interstinalparalysis, ileus, uncontrolled diabetes mellitus, uncontrolled angina, myocardial infarction within 6 months from onset, heart failure, other severe complications 5)Patients with active lung disease such as idopathic pulmonary fibrosis, pulmonary emphysema, severe chronic bronchitis, bronchial asthma 6)Patients with uncontrollable psychiatrical complications

研究者

发起方
Thoracic Surgery, Graduate School of Medicine, Chiba University

相似试验